We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.79B
AUM Growth
+$618M
Cap. Flow
+$595M
Cap. Flow %
33.32%
Top 10 Hldgs %
16.68%
Holding
4,499
New
1,229
Increased
1,153
Reduced
1,264
Closed
790

Sector Composition

Rank Sector Weight
1 Technology 13.59%
2 Financials 10.04%
3 Healthcare 8.35%
4 Industrials 7.34%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SH icon
3251
ProShares Short S&P500
SH
$897M
$3K ﹤0.01%
+25
New +$2.96K
SHOO icon
3252
Steven Madden
SHOO
$3.55B
$3K ﹤0.01%
80
-7,456
-99% -$250K
SLF icon
3253
Sun Life Financial
SLF
$45.4B
$3K ﹤0.01%
86
-11,259
-99% -$466K
SNFCA icon
3254
Security National Financial
SNFCA
$251M
$3K ﹤0.01%
816
+513
+169% +$1.81K
SNT
3255
Senstar Technologies
SNT
$43.2M
$3K ﹤0.01%
536
+31
+6% +$169
SQQQ icon
3256
ProShares UltraPro Short QQQ
SQQQ
$1.71B
-39
Closed -$1.54M
TGB
3257
Trekor Metals
TGB
$3.05B
$3K ﹤0.01%
2,400
+900
+60% +$1.06K
UBCP icon
3258
United Bancorp
UBCP
$96M
$3K ﹤0.01%
224
-76
-25% -$994
VIRT icon
3259
Virtu Financial
VIRT
$4.93B
$3K ﹤0.01%
110
-15,856
-99% -$512K
VRNA
3260
DELISTED
Verona Pharma
VRNA
$3K ﹤0.01%
255
-215
-46% -$3.62K
VRRM icon
3261
Verra Mobility
VRRM
$744M
$3K ﹤0.01%
+276
New +$2.78K
VYGR icon
3262
Voyager Therapeutics
VYGR
$198M
$3K ﹤0.01%
+151
New +$2.98K
ZEUS
3263
DELISTED
Olympic Steel
ZEUS
$3K ﹤0.01%
160
-3,056
-95% -$68.7K
NAGE
3264
Niagen Bioscience
NAGE
$247M
$3K ﹤0.01%
+835
New +$3.17K
CSA
3265
DELISTED
VictoryShares US Small Cap Volatility Wtd ETF
CSA
$3K ﹤0.01%
58
-42
-42% -$1.99K
FBMS
3266
DELISTED
The First Bancshares, Inc.
FBMS
$3K ﹤0.01%
+74
New +$2.49K
EIGR
3267
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$3K ﹤0.01%
+8
New +$2.85K
ARAV
3268
DELISTED
Aravive, Inc. Common Stock
ARAV
$3K ﹤0.01%
217
-3,231
-94% -$33.3K
SGEN
3269
DELISTED
Seagen Inc. Common Stock
SGEN
$3K ﹤0.01%
48
-6,958
-99% -$399K
APTO
3270
DELISTED
Aptose Biosciences, Inc.
APTO
$3K ﹤0.01%
+2
New +$3.19K
AVCT
3271
DELISTED
American Virtual Cloud Technologies, Inc. Common Stock
AVCT
$3K ﹤0.01%
21
-12
-36% -$1.77K
ALJJ
3272
DELISTED
ALJ Regional Holdings Inc
ALJJ
$3K ﹤0.01%
1,771
+978
+123% +$1.9K
SREV
3273
DELISTED
ServiceSource International, Inc.
SREV
$3K ﹤0.01%
+760
New +$3.02K
CALA
3274
DELISTED
Calithera Biosciences, Inc
CALA
$3K ﹤0.01%
+28
New +$3.17K
LEJU
3275
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$3K ﹤0.01%
+202
New +$2.57K

Similar funds

Tower Research Capital (TRC)'s Q2 2018 Portfolio in Review

As of Q2 2018, Tower Research Capital (TRC) held 4,499 positions worth $1.79B, up 53% from $1.17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Tower Research Capital (TRC) deployed $595M of net new capital in Q2 2018, opening 1,229 new positions and adding to 1,153 existing holdings. Its largest new stake was JPMorgan Chase: 180,678 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $31.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2018 buy was JPMorgan Chase: 180,678 shares worth $18.8M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2018, an estimated $51.7M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $31.8M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones REIT ETF in Q2 2018, selling an estimated $6.85M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 17% of its $1.79B portfolio in Q2 2018.
  • Tower Research Capital (TRC) opened 1,229 new positions and closed 790 in Q2 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 53% quarter-over-quarter to $1.79B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.